Application 204144
- Type
- ANDA
- Sponsor
- ANCHEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | TABLET, EXTENDED RELEASE;ORAL | 500MG; EQ 50MG BASE | No | No |
| 002 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | TABLET, EXTENDED RELEASE;ORAL | 1GM; EQ 50MG BASE | No | No |
| 003 | METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | TABLET, EXTENDED RELEASE;ORAL | 1GM; EQ 100MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | |
| A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | |
| A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204144-001 | AB |
| A204144-002 | AB |
| A204144-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2025-06-04 | 6a471c1ec25d… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-001 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-002 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-003 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-06-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A204144-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A204144-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A204144-003 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A204144-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204144-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204144-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A204144-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204144-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204144-003 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204144-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sitagliptin and Metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Par Health USA, LLC | 43e3b1c9-3cbd-8dc3-e063-6394a90a10a2 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 204144 ANDA204144 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.